The worldwide market for Next Generation Sequencers is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in

Major Region

s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Thermo Fisher Scientific, Inc. (U.S.)
BGI (China)
Roche Holding AG (Switzerland)
Macrogen Inc. (South Korea)
Pacific Biosciences of California, Inc. (U.S.)
Illumina, Inc. (U.S.)
QIAGEN N. V. (Germany)
Oxford Nanopore Technologies, Ltd. (U.K.)
Eurofins Scientific (Luxembourg)


Major Types Covered
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Sequencing by Ligation (SBL)
Pyrosequencing
Single-Molecule Real-time (SMRT) Sequencing
Other

Major Applications Covered
Diagnostics
Drug Discovery
Biomarker Discovery
Personalized Medicine
Agriculture and Animal Research
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…

Years considered for this report:

Historical Years:

2014-2018

Base Year:

2019

Estimated Year:

2019

Forecast Period:

2019-2026